Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
36.02
+0.97 (2.77%)
At close: Aug 18, 2026, 4:00 PM EDT
36.20
+0.18 (0.50%)
After-hours: Aug 18, 2026, 5:56 PM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.85 billion as of August 18, 2026. Its market cap has increased by 11.97% in one year.
Market Cap
1.85B
Enterprise Value
1.41B
1-Year Change
11.97%
Ranking
Category
Stock Price
$36.02
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has increased from $1.80B to $1.85B, an increase of 3.29%. That is a compound annual growth rate of 0.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.85B | 5.76% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.92B |
| Sarepta Therapeutics | 1.92B |
| Damora Therapeutics | 1.92B |
| Lakefront Biotherapeutics NV | 1.84B |
| Zymeworks | 1.80B |
| Braveheart Bio | 1.77B |
| AnaptysBio | 1.77B |
| Syndax Pharmaceuticals | 1.76B |